Log in

Southwest Riverside County Chapter

Event Registration

Log in

SWRC-CAMFT May Chapter Meeting and CE Presentation Ketamine Assisted Psychotherapy: A Transformative Treatment Option

  • 05/31/2024
  • 12:00 PM - 2:00 PM



Join us Friday, May 31st 12PM-2PM for 2 CEs Workshop presented by Celeste Monnette, LCSW and Dr. Tamar-Mattis           


FREE CEs to SWRC Chapter Members  

CEs $20 for Non-Members *PAY AFTER WORKSHOP

Ketamine Assisted Psychotherapy: A Transformative Treatment Option

Ketamine Assisted Psychotherapy (KAP) is at the forefront of the psychedelic psychotherapy movement. When used under proper medical and therapeutic supervision, ketamine can provide near-immediate relief from emotional pain, while helping individuals look deeply into themselves. It has been shown to quickly help with Treatment Resistant Depression (TRD) as well as chronic suicidal ideation. We find that ketamine’s healing potential is most effective when combined with psychotherapy from a trained provider. KAP can be a powerful tool to examine the unconscious processes that keep one stuck in negative and obsessive patterns.

KAP has been used to successfully treat PTSD, anxiety disorders, developmental trauma, phase of life issues, as well as helping clients navigate end of life and spiritual exploration. With careful attention to science, safety, and the individual needs of each client, KAP can lead to healing and transformation. This work can help clients transcend long-held narratives, feeling/mood states, and struggles that they may be having difficulty shifting with traditional psychotherapy and/or psychopharmacology. While there continues to be progress with clinical trials using psilocybin and MDMA to treat mental health disorders, ketamine is the psychedelic medicine that can currently be legally prescribed and supervised by trained, licensed professionals. Join the team at Liminal Medicine in Sebastopol to learn more about this modality and how you can collaborate with psychedelic therapists to assist your clients in deepening their work.

Educational Goals:

Understand what Ketamine is and what role it has in mental health treatment.

Become familiar with general principles of psychedelic-assisted psychotherapy, and understand the values and philosophies embedded in psychedelic medicine work as they contrast with psychiatric prescribing and conventional therapies.

Learning Objectives:

Understand key indications for KAP and have realistic expectations for potential treatment outcomes.

Feel confident and comfortable explaining basics of KAP to clients and prescribers, and developing a relationship with prescriber.

Be able to discuss/identify issues in ethics and care delivery in psychedelic medicine.

Be able to identify how group KAP may specifically benefit marginalized and underserved communities.

Celeste Monnette, LCSW, is a licensed psychotherapist with over 25 years of experience. She earned her Master’s degree in Social Welfare from UC Berkeley and has worked in community-based nonprofits and private practice. In 2005, she completed a two-year, post-graduate training program at The Psychotherapy Institute in Berkeley.

Since, she has been working with clients with a broad range of goals for symptom relief and healing through various therapeutic modalities. After discovering the power of Ketamine to heal and reduce suffering, Celeste’s professional focus and development began to center around ketamine work and psychedelic integration. Celeste is currently enrolled in the MDMA Therapy Training Program and has a particular interest in trauma and trauma-informed care. She recently co-authored a publication on Ketamine Assisted Psychotherapy (KAP). Celeste is currently a co-founder and the Clinical Director at Liminal Medicine.

Suegee Tamar-Mattis, DO, is board-certified in Family Medicine, certified in psychedelic-assisted therapies and research from the California Institute for Integral Studies, and trained in ketamine-assisted psychotherapy at the Polaris Insight Center. Dr. Tamar-Mattis has worked for many community organizations such as Sonoma County Indian Health Project and Brookwood Health Center (serving people experiencing homelessness), and was the founder of the transgender clinic at Santa Rosa Community Health Centers. Dr. Tamar-Mattis is a long-time advocate for the intersex community, serving as a consultant for Human Rights Watch and as a medical advisor to interACT: Advocates for Intersex Youth. Suegee has been practicing ketamine therapy full time since 2021, and is the Medical Director at Liminal Medicine, a clinic focusing on ketamine-assisted psychotherapy.


Stein, M. B., & Simon, N. M. (2021). Ketamine for PTSD: Well, Isn't That Special. The American journal of psychiatry, 178(2), 116–118.

Halstead, M., Reed, S., Krause, R., & Williams, M. T. (2021). Ketamine-Assisted Psychotherapy for PTSD Related to Racial Discrimination. Clinical Case Studies, 20(4), 310–330.

McInnes, L. A., Qian, J. J., Gargeya, R. S., DeBattista, C., & Heifets, B. D. (2022). A retrospective analysis of ketamine intravenous therapy for depression in real-world care settings. Journal of affective disorders, 301, 486–495.

Zydb, T., & Hart, M. (2021). Efficacy of Oral Ketamine Combined with Psychotherapy for Treatment Resistant Depression. European Journal of Medical and Health Sciences, 3(4), 106–108.

Gold, S., & Quinones, M. (2022, February 17). Mind blog: Ketamine in contextual trauma therapy: The paradox of dissociation. MIND Foundation.

Contact Information for Presenters:

All presenters can be reached through the following contact:

Anne Tamar-Mattis, Chief Administrative Officer

Liminal Medicine

1020 Gravenstein Hwy S., Suite 120

Sebastopol, CA 95472

(707) 861-0807

Copyright © 2007 - 2022 SWRC-CAMFT all rights reserved